Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

415.21 -2.63 (-0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
69 70 Next >
News headline image
The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns ↗
The Dogs of the Dow strategy is one of the best yearly strategies investors should use to make some good money. 
Via InvestorPlace
Topics Stocks
News headline image
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks ↗
With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks. 
Via InvestorPlace
News headline image
The AI Race Gets Litigious ↗
We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 ↗
Explore President Biden's plan to expand Medicare drug negotiations, targeting at least 50 drugs annually. Uncover the impact on pharmaceutical profits and the broader health-care policy proposals,... 
Via Benzinga
News headline image
(AMGN) - Analyzing Amgen's Short Interest ↗
 
Via Benzinga
News headline image
Amgen Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks? ↗
It's only a bargain price if it's actually worth owning. 
Via The Motley Fool
Topics Stocks
News headline image
It’s Time! 3 Dodgy Pharma Stocks to Sell in February ↗
Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action. 
Via InvestorPlace
News headline image
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? ↗
The biotech tantalized investors with a very promising data update. 
Via The Motley Fool
News headline image
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says. 
Via Investor's Business Daily
News headline image
Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List ↗
Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant. 
Via Benzinga
News headline image
This Is What Whales Are Betting On Amgen ↗
 
Via Benzinga
News headline image
Behind the Scenes of Amgen's Latest Options Trends ↗
 
Via Benzinga
News headline image
Why the dividend investor may take a look at NASDAQ:AMGN. ↗
Exploring AMGEN INC (NASDAQ:AMGN)'s dividend characteristics. 
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years ↗
It will take a lot, but this goal isn't out of reach for these stocks. 
Via The Motley Fool
News headline image
Better Dividend Growth Stock: AbbVie or Amgen? ↗
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy. 
Via The Motley Fool
News headline image
Amazon Stock: Why it's Finally Included in the Dow Index
Amazon replaced Walgreens in the Dow. While a positive move for Amazon, any impact on the stock's price may be limited due to low index weighting. 
Via MarketBeat
Topics Economy Stocks
News headline image
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs ↗
Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and... 
Via Benzinga
News headline image
3 Biotech Stocks to Buy and Hold for the Next 10 Years ↗
There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon. 
Via The Motley Fool
News headline image
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. 
Via InvestorPlace
News headline image
If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today ↗
Has Amgen been a market-beating stock? 
Via The Motley Fool
News headline image
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness ↗
Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts. 
Via InvestorPlace
News headline image
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive. 
Via InvestorPlace
News headline image
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade ↗
Investors interested in a steadily rising stream of passive income will find what they're looking for with these dividend payers. 
Via The Motley Fool
Topics Stocks
News headline image
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy? ↗
It faces both clinical and competitive barriers, but they might not matter. 
Via The Motley Fool
News headline image
Drivers And Stock Pickers ↗
As opposed to drivers who overestimate themselves, we seek to be above-average stock pickers by doing the things that most professional investors struggle with, like being courageous and patient. 
Via Talk Markets
News headline image
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review ↗
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.